$IMPL IMPEL NEUROPHARMA INC Insider Trading
Get free email notifications about insider trading in IMPEL NEUROPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IMPEL NEUROPHARMA INC. Insider overview, share value development, latest insider transactions and email notifications about new events in IMPEL NEUROPHARMA INC for free.
CIK Number: 0001445499
IRS Number: 263058238
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: IMPL
Company Address: 201 ELLIOTT AVE. W SUITE 260 SEATTLE 98119
Phone number: 206-568-1466
IMPEL NEUROPHARMA INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 713,064 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 5,162,969 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 995,714 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,206,216 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,073,308 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,772,634 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,605,711 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,628,174 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 69,380 | 1,040,700 | 349,674 | 280.3 K to 349.7 K (+24.75 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 505,620 | 7,584,300 | 2,535,115 | 2 M to 2.5 M (+24.91 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 13.50 | 12,311 | 166,199 | 280,294 | 268 K to 280.3 K (+4.59 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 13.50 | 89,145 | 1,203,458 | 2,029,495 | 1.9 M to 2 M (+4.59 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 43,550 | 0 | 267,983 | 224.4 K to 268 K (+19.40 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 315,328 | 0 | 1,940,350 | 1.6 M to 1.9 M (+19.40 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 60,813 | 0 | 224,433 | 163.6 K to 224.4 K (+37.17 %) |